共 93 条
Mapping the Druggable Allosteric Space of G-Protein Coupled Receptors: a Fragment-Based Molecular Dynamics Approach
被引:89
作者:
Ivetac, Anthony
[1
]
McCammon, J. Andrew
[1
,2
,3
,4
]
机构:
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
基金:
美国国家科学基金会;
美国国家卫生研究院;
关键词:
allosteric;
docking;
fragment-based;
GPCR;
molecular dynamics;
COMPUTATIONAL DRUG DESIGN;
RELAXED COMPLEX SCHEME;
LIGAND BINDING-SITES;
BETA(2)-ADRENERGIC RECEPTOR;
CRYSTAL-STRUCTURE;
HOT-SPOTS;
STRUCTURAL INSIGHTS;
MEMBRANE-PROTEIN;
SIMULATIONS;
DISCOVERY;
D O I:
10.1111/j.1747-0285.2010.01012.x
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
To address the problem of specificity in G-protein coupled receptor (GPCR) drug discovery, there has been tremendous recent interest in allosteric drugs that bind at sites topographically distinct from the orthosteric site. Unfortunately, structure-based drug design of allosteric GPCR ligands has been frustrated by the paucity of structural data for allosteric binding sites, making a strong case for predictive computational methods. In this work, we map the surfaces of the beta(1) (beta(1)AR) and beta(2) (beta(2)AR) adrenergic receptor structures to detect a series of five potentially druggable allosteric sites. We employ the FTMAP algorithm to identify 'hot spots' with affinity for a variety of organic probe molecules corresponding to drug fragments. Our work is distinguished by an ensemble-based approach, whereby we map diverse receptor conformations taken from molecular dynamics (MD) simulations totaling approximately 0.5 mu s. Our results reveal distinct pockets formed at both solvent-exposed and lipid-exposed cavities, which we interpret in light of experimental data and which may constitute novel targets for GPCR drug discovery. This mapping data can now serve to drive a combination of fragment-based and virtual screening approaches for the discovery of small molecules that bind at these sites and which may offer highly selective therapies.
引用
收藏
页码:201 / 217
页数:17
相关论文